Close Menu
Home » Oxford Nanopore

Oxford Nanopore

Oxford Nanopore Technologies was founded in 2005 to develop an electronic, single molecule sensing system based on nanopore science. The company now has more than 250 employees from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialization. Oxford Nanopore's instruments — MinIon, PromethIon, and GridIon are adaptable for the analysis of DNA, RNA, proteins, small molecules and other types of molecule.

Oxford Nanopore Facts

 

CEO: Gordon Sanghera

Website: www.nanoporetech.com

Ticker symbol: Privately held

Headquarters: Oxford, UK

Number of employees: 250+

Nov 04, 2019

Shield Bio Brings Nanopore Sequencing to Patients Through STI Test Service

Premium

A San Jose, California-based company appears to be the first in the US to routinely offer nanopore sequencing as part of a testing lab service. 

Sep 24, 2019

NIH Awards $29.5M to Two Centers for New Human Genome Reference Program

Using 350 human genomes from different populations, the two centers plan to develop a multi-genome reference sequence that is as complete as possible.

Sep 19, 2019

Oxford Nanopore Licenses CRISPR-Cas9 IP From Caribou Biosciences for Targeted Nanopore Sequencing

The firm said CRISPR will enable targeted sequencing of long regions of interest that were previously only accessible with long-read whole-genome sequencing.

Sep 11, 2019

Oxford Nanopore Responds in Court to Pacific Biosciences Allegations of Willful Infringement

The UK-based sequencing technology firm continues to seek invalidation of PacBio's patents, despite unsuccessful earlier efforts.

Sep 03, 2019

Denmark's Samplix Plans Commercial Expansion to Support Rollout of Xdrop System

Premium

The company believes that Xdrop will find adopters in academia and clinical research, although diagnostics is on its radar.

Jul 18, 2019

European Patent Office Revokes Second Pacific Biosciences Patent

The patent, EP3170904, "Compositions and methods for nucleic acid sequencing," is the second PacBio patent revoked by the EPO this year. 

Jul 08, 2019

Oxford Nanopore 2018 Revenues More Than Double; Firm Opens New Production Facility

In a message posted on Twitter today, Oxford Nanopore said that revenues grew to $43.7 million last year, up from $17.8 million in 2017.

May 24, 2019

Oxford Nanopore Previews Upcoming Products, Outlines Nanopore-Based DNA Data Storage Tech

Premium

At the company's annual user meeting in London, staff members previewed upgrades and changes that will result in higher throughput and accuracy at lower sequencing costs.

Apr 29, 2019

GrandOmics, Oxford Nanopore Partner on 100K Human Genomes Structural Variation Project

The project plans to sequence 20,000 genomes in 2019, 50,000 by the end of 2020, and a total of 100,000 by the end of 2021 using Oxford Nanopore's PromethIon platform.

Apr 19, 2019

Oxford Nanopore Sequencing Shows Promise for Diagnosing Prosthetic Joint Infections

Premium

The method, presented at the European Congress of Clinical Microbiology and Infectious Diseases, may provide results in hours rather than a week or more.

Pages

The Scan

Whittling Down the Database

The New York City Police Department will be removing DNA profiles from a local database if they are from people who were never convicted of a crime, the New York Times reports.

Accusations and Certifications

Science reports that accusations of sexual assault against a microbiome researcher has also led to questions about his academic certifications.

DNA That Floats Behind

Wired reports that researchers are analyzing the DNA fish leave behind in water to study their populations.

Science Papers Include Thymus Cellular Map, Ancient Archaic Hominin Admixture

In Science this week: comprehensive cellular map of the human thymus, evidence of admixture between the ancestors of Neanderthals and Denisovan and a 'superarchaic' population.

What's Popular?

In Oxford Nanopore

  1. BC Centre for Disease Control Launches Genomic Study to Track SARS-CoV-2

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.